Real-time enrollment status for this hypereosinophilic syndrome clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT05334368 |
| Recruiting Status | Recruiting |
| Condition | Hypereosinophilic Syndrome |
| Phase | Clinical Trial |
| Target Enrollment | 123 participants |
| Active Locations | 8 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | November 25, 2025 (Nov 25, 2025) |
As of March 2, 2026: Clinical trial NCT05334368 is currently recruiting participants. This clinical trial study for hypereosinophilic syndrome is actively seeking new participants at 8 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05334368 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05334368 was last updated Nov 25, 2025 (November 25, 2025). HelloStudys verifies this status automatically.